267 related articles for article (PubMed ID: 29162389)
1. Is cryptogenic cirrhosis different from NASH cirrhosis?
Thuluvath PJ; Kantsevoy S; Thuluvath AJ; Savva Y
J Hepatol; 2018 Mar; 68(3):519-525. PubMed ID: 29162389
[TBL] [Abstract][Full Text] [Related]
2. Liver Transplantation in Cryptogenic Cirrhosis: Outcome Comparisons Between NASH, Alcoholic, and AIH Cirrhosis.
Thuluvath PJ; Hanish S; Savva Y
Transplantation; 2018 Apr; 102(4):656-663. PubMed ID: 29215462
[TBL] [Abstract][Full Text] [Related]
3. Waiting List Mortality and Transplant Rates for NASH Cirrhosis When Compared With Cryptogenic, Alcoholic, or AIH Cirrhosis.
Thuluvath PJ; Hanish S; Savva Y
Transplantation; 2019 Jan; 103(1):113-121. PubMed ID: 29985186
[TBL] [Abstract][Full Text] [Related]
4. Cryptogenic cirrhosis and NASH: entities in evolution and involution.
Mahiuddin Ahammed SK; Chowdhury A
Trop Gastroenterol; 2014; 35(2):65-70. PubMed ID: 25470867
[TBL] [Abstract][Full Text] [Related]
5. Post-transplantation outcome in non-alcoholic steatohepatitis cirrhosis: Comparison with alcoholic cirrhosis.
Castelló B; Aguilera V; Blázquez MT; Rubín Á; García M; Vinaixa C; Benlloch S; SanJuan F; Montalva E; López R; Berenguer M
Ann Hepatol; 2019; 18(6):855-861. PubMed ID: 31543468
[TBL] [Abstract][Full Text] [Related]
6. Cryptogenic cirrhosis: clinical characterization and risk factors for underlying disease.
Caldwell SH; Oelsner DH; Iezzoni JC; Hespenheide EE; Battle EH; Driscoll CJ
Hepatology; 1999 Mar; 29(3):664-9. PubMed ID: 10051466
[TBL] [Abstract][Full Text] [Related]
7. Risk factors for nonalcoholic steatohepatitis in cryptogenic cirrhosis.
Leite AB; Mattos AA; Mattos AZ; Coral GP; Evaldt S
Arq Gastroenterol; 2012 Dec; 49(4):245-9. PubMed ID: 23329217
[TBL] [Abstract][Full Text] [Related]
8. The conundrum of cryptogenic cirrhosis: Adverse outcomes without treatment options.
Younossi Z; Stepanova M; Sanyal AJ; Harrison SA; Ratziu V; Abdelmalek MF; Diehl AM; Caldwell S; Shiffman ML; Schall RA; McColgan B; Subramanian GM; Myers RP; Muir A; Afdhal NH; Bosch J; Goodman Z
J Hepatol; 2018 Dec; 69(6):1365-1370. PubMed ID: 30144554
[TBL] [Abstract][Full Text] [Related]
9. Liver Transplantation (LT) for Cryptogenic Cirrhosis (CC) and Nonalcoholic Steatohepatitis (NASH) Cirrhosis: Data from the Scientific Registry of Transplant Recipients (SRTR): 1994 to 2016.
Golabi P; Bush H; Stepanova M; Locklear CT; Jacobson IM; Mishra A; Trimble G; Erario M; Venkatesan C; Younossi I; Goodman Z; Younossi ZM
Medicine (Baltimore); 2018 Aug; 97(31):e11518. PubMed ID: 30075518
[TBL] [Abstract][Full Text] [Related]
10. Prevalence of obesity and diabetes in patients with cryptogenic cirrhosis: a case-control study.
Poonawala A; Nair SP; Thuluvath PJ
Hepatology; 2000 Oct; 32(4 Pt 1):689-92. PubMed ID: 11003611
[TBL] [Abstract][Full Text] [Related]
11. The post-transplant course of patients undergoing liver transplantation for nonalcoholic steatohepatitis versus cryptogenic cirrhosis: a retrospective case-control study.
Unger LW; Herac M; Staufer K; Salat A; Silberhumer G; Hofmann M; Trauner M; Rasoul-Rockenschaub S; Soliman T; Reiberger T; Berlakovich GA
Eur J Gastroenterol Hepatol; 2017 Mar; 29(3):309-316. PubMed ID: 27922486
[TBL] [Abstract][Full Text] [Related]
12. Patients with NASH and cryptogenic cirrhosis are less likely than those with hepatitis C to receive liver transplants.
O'Leary JG; Landaverde C; Jennings L; Goldstein RM; Davis GL
Clin Gastroenterol Hepatol; 2011 Aug; 9(8):700-704.e1. PubMed ID: 21570483
[TBL] [Abstract][Full Text] [Related]
13. Poor Survival After Retransplantation in NASH Cirrhosis.
Thuluvath AJ; Chen PH; Thuluvath PJ; Kantsevoy S; Savva Y
Transplantation; 2019 Jan; 103(1):101-108. PubMed ID: 29470354
[TBL] [Abstract][Full Text] [Related]
14. Chronic liver disease in diabetes mellitus.
Amarapurkar D; Das HS
Trop Gastroenterol; 2002; 23(1):3-5. PubMed ID: 12170918
[TBL] [Abstract][Full Text] [Related]
15. Most Cases of Cryptogenic Cirrhosis May Be Nonobese Nonalcoholic Steatohepatitis - Risk Factors of Liver Steatosis After Liver Transplantation for Cryptogenic Cirrhosis: A Retrospective Study.
Fukushima M; Miyaaki H; Sasaki R; Haraguchi M; Miuma S; Hara T; Soyama A; Hidaka M; Eguchi S; Nakao K
Intern Med; 2023 May; 62(10):1415-1423. PubMed ID: 36171128
[TBL] [Abstract][Full Text] [Related]
16. Prevalence of metabolic syndrome, obesity and diabetes type 2 in cryptogenic cirrhosis.
Tellez-Avila FI; Sanchez-Avila F; García-Saenz-de-Sicilia M; Chavez-Tapia NC; Franco-Guzman AM; Lopez-Arce G; Cerda-Contreras E; Uribe M
World J Gastroenterol; 2008 Aug; 14(30):4771-5. PubMed ID: 18720537
[TBL] [Abstract][Full Text] [Related]
17. Risks and clinical predictors of cirrhosis and hepatocellular carcinoma diagnoses in adults with diagnosed NAFLD: real-world study of 18 million patients in four European cohorts.
Alexander M; Loomis AK; van der Lei J; Duarte-Salles T; Prieto-Alhambra D; Ansell D; Pasqua A; Lapi F; Rijnbeek P; Mosseveld M; Waterworth DM; Kendrick S; Sattar N; Alazawi W
BMC Med; 2019 May; 17(1):95. PubMed ID: 31104631
[TBL] [Abstract][Full Text] [Related]
18. The epidemiology of non-alcoholic steatohepatitis (NASH) in the United States between 2010-2020: a population-based study.
Hamid O; Eltelbany A; Mohammed A; Alsabbagh Alchirazi K; Trakroo S; Asaad I
Ann Hepatol; 2022; 27(5):100727. PubMed ID: 35700934
[TBL] [Abstract][Full Text] [Related]
19. Clinical characteristics of patients with cryptogenic liver cirrhosis in Okinawa, Japan.
Sakugawa H; Nakasone H; Nakayoshi T; Kawakami Y; Yamashiro T; Maeshiro T; Kobashigawa K; Kinjo F; Saito A
Hepatogastroenterology; 2003; 50(54):2005-8. PubMed ID: 14696453
[TBL] [Abstract][Full Text] [Related]
20. Expanding the natural history of nonalcoholic steatohepatitis: from cryptogenic cirrhosis to hepatocellular carcinoma.
Bugianesi E; Leone N; Vanni E; Marchesini G; Brunello F; Carucci P; Musso A; De Paolis P; Capussotti L; Salizzoni M; Rizzetto M
Gastroenterology; 2002 Jul; 123(1):134-40. PubMed ID: 12105842
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
